sec filing
IC
NASDAQ · ICCC
ImmuCell Corporation
Healthcare · Biotechnology
$9.71
Down-$0.14 (-1.42%)
Updated Sep 15, 2026, 3:32 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 54.28M
- P/E ratio
- 23.36
- Dividend yield
- 0.00%
- 52-week range
- $6.00 – $12.10
- Volume
- 14.82K
- Avg. volume
- 18.99K
Price performance
ICCC price history
1M range · 20 trading sessions · Daily adjusted prices
ICCC closed at $9.71 after 20 trading sessions, up 0.10% for the selected period.
- Last close
- $9.71
- Period change
- +0.10%
- Period low
- $9.70
- Period high
- $10.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $9.80 | $9.85 | $9.71 | $9.71 | 14.82K |
| Sep 11, 2026 | $9.91 | $9.91 | $9.6341 | $9.85 | 8.1K |
| Sep 10, 2026 | $9.84 | $10.00 | $9.765 | $9.915 | 11.26K |
| Sep 9, 2026 | $9.81 | $9.95 | $9.79 | $9.91 | 8.5K |
| Sep 8, 2026 | $9.82 | $10.02 | $9.80 | $9.84 | 15.55K |
| Sep 4, 2026 | $9.97 | $9.97 | $9.80 | $9.90 | 11.7K |
| Sep 3, 2026 | $9.90 | $10.0399 | $9.90 | $10.00 | 14.27K |
| Sep 2, 2026 | $9.825 | $10.09 | $9.825 | $10.00 | 16.28K |
| Sep 1, 2026 | $9.85 | $10.015 | $9.835 | $9.92 | 6.99K |
| Aug 31, 2026 | $9.86 | $10.00 | $9.77 | $9.79 | 20.13K |
| Aug 28, 2026 | $10.298 | $10.298 | $9.89 | $9.94 | 5.61K |
| Aug 27, 2026 | $10.00 | $10.155 | $10.00 | $10.02 | 3.18K |
| Aug 26, 2026 | $9.85 | $10.3396 | $9.85 | $10.02 | 7.43K |
| Aug 25, 2026 | $9.87 | $10.12 | $9.73 | $9.84 | 27.47K |
| Aug 24, 2026 | $10.06 | $10.06 | $9.76 | $9.84 | 54.67K |
| Aug 21, 2026 | $10.09 | $10.4933 | $10.0501 | $10.06 | 11.13K |
| Aug 20, 2026 | $10.14 | $10.26 | $9.775 | $10.09 | 83.72K |
| Aug 19, 2026 | $9.76 | $10.375 | $9.61 | $10.13 | 48.76K |
| Aug 18, 2026 | $9.73 | $9.86 | $9.6291 | $9.76 | 15.15K |
| Aug 17, 2026 | $10.00 | $10.00 | $9.55 | $9.70 | 100.99K |
Latest ICCC news
The latest Smart Investors Daily articles mentioning ICCC.
Stock researchResearch & News · News
Loading stock research…

